Ontology highlight
ABSTRACT: Background
TNF-related apoptosis inducing ligand (TRAIL) belongs to the TNF-superfamily that induces apoptotic cell death in a wide range of neoplastic cells in vivo as well as in vitro. We identified two alternative TRAIL-splice variants, i.e. TRAIL-? and TRAIL-? that are characterized by the loss of their proapoptotic properties. Herein, we investigated the expression and the prognostic values of the TRAIL-splice variants in gastric carcinomas.Methods
Real time PCR for amplification of the TRAIL-splice variants was performed in tumour tissue specimens and corresponding normal tissues of 41 consecutive patients with gastric carcinoma. Differences on mRNA-expression levels of the TRAIL-isoforms were compared to histo-pathological variables and correlated with survival data.Results
All three TRAIL-splice variants could be detected in both non-malignant and malignant tissues, irrespective of their histological staging, grading or tumour types. However, TRAIL-? exhibited a higher expression in normal gastric tissue. The proapoptotic TRAIL-? expression was increased in gastric carcinomas when compared to TRAIL-? and TRAIL-?. In addition, overexpression of TRAIL-? was associated with a significant higher survival rate.Conclusions
This is the first study that investigated the expression of TRAIL-splice variants in gastric carcinoma tissue samples. Thus, we provide first data that indicate a prognostic value for TRAIL-? overexpression in this tumour entity.
SUBMITTER: Krieg A
PROVIDER: S-EPMC3751299 | biostudies-literature | 2013 Aug
REPOSITORIES: biostudies-literature
Krieg Andreas A Mersch Sabrina S Wolf Nadine N Stoecklein Nikolas H NH Verde Pablo E PE am Esch Jan Schulte JS Heikaus Sebastian S Gabbert Helmut E HE Knoefel Wolfram T WT Mahotka Csaba C
BMC cancer 20130812
<h4>Background</h4>TNF-related apoptosis inducing ligand (TRAIL) belongs to the TNF-superfamily that induces apoptotic cell death in a wide range of neoplastic cells in vivo as well as in vitro. We identified two alternative TRAIL-splice variants, i.e. TRAIL-β and TRAIL-γ that are characterized by the loss of their proapoptotic properties. Herein, we investigated the expression and the prognostic values of the TRAIL-splice variants in gastric carcinomas.<h4>Methods</h4>Real time PCR for amplific ...[more]